4 completed, 4 unknown, 1 enrolling by invitation, 1 recruiting. 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Xeroderma Pigmentosum: new trials by email Literature Review of Xeroderma Pigmentosum trials Research Report on Xeroderma Pigmentosum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reproductive Options in Inherited Skin Diseases Ichthyosis, Palmoplantar Keratoses | Enrolling by invitation | Maastricht University Medical Center | 650 | 2024-01-01 | 2025-05-18 | |
| Natural History Study for DNA Repair Disorders Interval History, Physical Examination, ECAB Assessment - DNA Repair Disorder, Cockayne Syndrome | Recruiting | University of Minnesota | 40 | 2022-10-01 | 2026-05-27 | |
| A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V Afamelanotide - Xeroderma Pigmentosum | Phase 2 | Unknown | Clinuvel Europe Limited | 6 | 2022-03-28 | 2023-09-21 |
| A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP) Afamelanotide - Xeroderma Pigmentosum | Phase 2 | Unknown | Clinuvel Europe Limited | 6 | 2021-10-19 | 2023-06-18 |
| Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study Biospecimen Collection, Ipilimumab, Nivolumab - Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2021-05-11 | 2026-06-10 | |
| A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle - Recurrent Basal Cell Carcinoma | Phase 2 | Terminated | Sol-Gel Technologies, Ltd. | 50 | 2019-12-20 | 2026-07-21 |
| Epidemiological Description of the Kaposi's Disease in France's Southeast Kaposi's Disease | Unknown | Direction Centrale du Service de Santé des Armées | 100 | 2018-08-01 | 2019-05-14 | |
| XPAND Trial: Enhancing XP Photoprotection Activities - New Directions XPAND - Xeroderma Pigmentosum | Not applicable | Completed | Guy's and St Thomas' NHS Foundation Trust | 15 | 2018-03-30 | 2020-07-22 |
| Xeroderma Pigmentosum Patient Experiences Survey Study - Xeroderma Pigmentosum | Unknown | Henry Ford Health System | 15 | 2009-07-01 | 2010-05-14 | |
| Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients Skin Cancer, Xeroderma Pigmentosum | Completed | Medical University of Graz | 13 | 2004-10-01 | 2009-09-30 | |
| Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum Xeroderma Pigmentosum, Basal Cell Carcinoma | Completed | National Cancer Institute (NCI) | 301 | 2003-04-07 | 2024-01-08 | |
| Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy Cockayne Syndrome, Skin Neoplasms | Completed | National Cancer Institute (NCI) | 709 | 1999-05-10 | 2026-11-09 |
Basal Cell Nevus Syndrome (3) · Skin Neoplasms (3) · Carcinoma, Basal Cell (2) · Cockayne Syndrome (2) · Trichothiodystrophy Syndromes (2) · Albinism (1) · Birt-Hogg-Dube Syndrome (1) · Carcinoma, Squamous Cell (1) · Central Nervous System Neoplasms (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Cutis Laxa (1) · DNA Repair-Deficiency Disorders (1) · Ectodermal Dysplasia (1) · Epidermolysis Bullosa (1)
Congenital Abnormalities (12) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12) · Genetic Diseases, Inborn (12) · Metabolic Diseases (12) · Neoplasms (12) · Nutritional and Metabolic Diseases (12) · Photosensitivity Disorders (12) · Pigmentation Disorders (12) · Precancerous Conditions (12) · Skin Abnormalities (12) · Skin Diseases (12) · Skin and Connective Tissue Diseases (12) · DNA Repair-Deficiency Disorders (11) · Skin Diseases, Genetic (11) · Abnormalities, Multiple (5)
afamelanotide (2) · CTLA-4 Antigen (1) · Ipilimumab (1) · Longitudinal Studies (1) · Nivolumab (1) · Restraint, Physical (1) · Specimen Handling (1)
National Cancer Institute (NCI) (3) · Clinuvel Europe Limited (2) · Direction Centrale du Service de Santé des Armées (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Henry Ford Health System (1) · Maastricht University Medical Center (1) · Medical University of Graz (1) · Sol-Gel Technologies, Ltd. (1) · University of Minnesota (1)
United States (6) · Austria (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Netherlands (1) · Spain (1) · United Kingdom (1)
Antoni Gostynski, MD, PhD (1) · Daniel A Morgenstern (1) · Henry W Lim, M.D. (1) · John Weinman, PhD, FbPsS (1) · Kenneth H Kraemer, M.D. (1) · Michael R Sargen, M.D. (1) · Peter Kang, MD (1) · Peter Wolf, MD (1) · Robert Sarkany, FRCP MD CCST (1)
PMID 24918982, PMID 31320353, PMID 31503159
P30CA015704 (1), UM1CA154967 (1)